OPPENHEIMER ASSET MANAGEMENT INC. - AIMMUNE THERAPEUTICS INC ownership

Quarter-by-quarter ownership
OPPENHEIMER ASSET MANAGEMENT INC. ownership history of AIMMUNE THERAPEUTICS INC
ValueSharesWeighting
Q2 2020$393,000
+17.7%
23,498
+1.4%
0.01%0.0%
Q1 2020$334,000
-57.9%
23,167
-2.2%
0.01%
-52.9%
Q4 2019$793,000
+120.3%
23,687
+37.6%
0.02%
+112.5%
Q3 2019$360,000
+148.3%
17,210
+147.3%
0.01%
+166.7%
Q2 2019$145,000
-19.4%
6,958
-13.7%
0.00%
-25.0%
Q1 2019$180,000
+56.5%
8,065
+67.7%
0.00%
+33.3%
Q4 2018$115,0004,8100.00%
Other shareholders
AIMMUNE THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Chicago Capital Management, LLC 414,500$14,280,00013.67%
Burrage Capital Management LLC 332,546$11,456,0009.04%
Penn Mutual Asset Management, LLC 158,783$5,470,0007.72%
First Trust Capital Management L.P. 525,598$18,107,0004.87%
GARDNER LEWIS ASSET MANAGEMENT L P 653,711$22,520,0004.08%
ALPINE ASSOCIATES MANAGEMENT INC. 2,075,100$71,488,0003.76%
S. MUOIO & CO. LLC 90,000$3,101,0003.52%
EQUITEC PROPRIETARY MARKETS, LLC 124,700$4,296,0003.27%
GABELLI & Co INVESTMENT ADVISERS, INC. 501,719$17,284,0003.11%
WATER ISLAND CAPITAL LLC 1,062,245$36,594,0003.11%
View complete list of AIMMUNE THERAPEUTICS INC shareholders